IMDX
Insight Molecular Diagnostics Inc.
NASDAQ: IMDX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$3.83
-8.81% today
Updated 2026-04-29
Market cap
$123.53M
P/E ratio
—
P/S ratio
30.46x
EPS (TTM)
$-1.65
Dividend yield
—
52W range
$2 – $9
Volume
0.3M
Insight Molecular Diagnostics Inc. (IMDX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-710000.00 | $-1.16M | $-4.23M | $-7.52M | $-13.38M | $-11.65M | $-19.71M | $-25.98M | $-35.94M | $-45.57M | $-23.32M | $-20.71M | $-22.18M |
| Capital expenditures | $25000.00 | $9000.00 | $500000.00 | $106000.00 | $91000.00 | $31000.00 | $918000.00 | $1.23M | $2.25M | $4.34M | $281000.00 | $516000.00 | $3.19M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $326000.00 | $318000.00 | $1.81M | $922000.00 | $1.63M | $1.48M | $3.00M | $5.07M | $6.84M | $10.04M | $6.57M | $1.91M | $2.22M |
| Free cash flow | $-735000.00 | $-1.17M | $-4.73M | $-7.63M | $-13.48M | $-11.68M | $-20.63M | $-27.21M | $-38.19M | $-49.91M | $-23.61M | $-21.23M | $-25.37M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $96000.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — |